Anxiety and Depression Treatment Market is estimated to be US$ 13.85 billion by 2030 with a CAGR of 2.7% during the forecast period 2030


 Anxiety and Depression Treatment Market accounted for US$ 10.89 billion in 2020 and is estimated to be US$ 13.85 billion by 2030 and is anticipated to register a CAGR of 2.7%. Anxiety and Depression are two types of mood disorders. Anxiety creates feelings of nervousness, worry or dread. Feeling of sadness, reduced energy and feeling loneliness are symptoms of Depression. Anxiety & Depression lead to chronic fatigue, tiredness & lack of energy. Due to over stress and overthinking the human body cannot handle the emotions and begins to shut down which is manifested by extreme fatigue and tiredness. Covid-19 Pandemic has increased the mental illness among people. Thus, newly drugs, therapies in market are highly recommended. 

The report “ Global Anxiety and Depression Treatment Market By Product (Antidepressant Drugs, SSRIs (Selective Serotonin Reuptake Inhibitor), SNRIs (Serotonin-Norepinephrine Reuptake Drug), Benzodiazepine, Devices and Therapy), By Indication (MDD (Major Depressive Disorder), OCD (Obsessive-Compulsive Disorder), Phobia), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030  “

Key Highlights:

  • March 2022, COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. The wakeup call to all countries to step up mental health services and support. Increase in drug development has raised due to pandemic.
  • March 2019, FDA approves new nasal spray medication for treatment –resistant depression; available only at a certified doctor’s office or clinic. FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them.

Analyst View:

Due to increase in prevalence of anxiety and depression worldwide. Newly medications is must which are easily available & cost affordable for patients. Increase in research and development to bring up new drug available in market is highly recommended. This can give the boost growth in target market.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4899

Key Market Insights from the report:

Global Anxiety and Depression Treatment Market accounted for US$ 10.89 billion in 2020 and is estimated to be US$ 13.85 billion by 2030 and is anticipated to register a CAGR of 2.7%. The Global Anxiety and Depression Treatment Market is segmented based on Product, Indication, Distribution Channel and Region.

  • Based on Product, Global Anxiety and Depression Treatment Market is segmented into Antidepressant drugs, SSRIs (Selective Serotonin Reuptake Inhibitor), SNRIs (Serotonin-Norepinephrine Reuptake Drug), Benzodiazepine, Devices and Therapy.
  • Based on Indication, Global Anxiety and Depression Treatment Market is segmented into MDD (Major Depressive Disorder), OCD (Obsessive-Compulsive Disorder, Phobia.
  • Based on distribution channel, Global Anxiety and Depression Treatment Market is classified into hospital pharmacy, retail pharmacy, and online pharmacy and others.
  • By Region, the Global Anxiety and Depression Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Anxiety and Depression Treatment:

The prominent players operating in the Global Anxiety and Depression Treatment Market includes, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, Merck & Co. Inc., AstraZeneca, Bristol-Myers Sqibb, Lundbeck A/S, GlaxoSmithKline plc., Novartis AG, Sanofi, Cipla Ltd., Glenmark Life Sciences Limited, Lupin Limited, Sun Pharmaceutical Industries Ltd., Intas Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co. Ltd., and Others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Osteoporosis Treatment Market is estimated to be US$ 17.68 billion by 2030 with a CAGR of 4.3% during the forecast period

Image
  The   Osteoporosis Treatment Market   accounted for US$ 11.60 billion in 2020 and is estimated to be US$ 17.68 billion by 2030 and is anticipated to register a CAGR of 4.3%. Osteoporosis is a condition in which body loses too much bone and there is an increase in bone weakness. The individual suffering from osteoporosis is more exposed to bone fractures. Hence, a proper treatment is required to cure and avoid the chances of complications. Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The report “ Global Osteoporosis Treatment Market By Drugs Type (Selective Estrogen Receptor Modulators (SERMs), Rank Ligand (RANKL) Inhibitor, Calcitonin, Hormone Therapy, Parathyroid Hormone-Related Protein (PTHrP) Analog, and Bisphosphonates (Risedrona
Read more

Hand Sanitizers Market is estimated to be US$ 2.70 billion by 2030 with a CAGR of 7.50% during the forecast period

Image
  Hand Sanitizers Market  accounted for US$ 1.31 billion in 2020 and is estimated to be US$ 2.70 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hand sanitizer is an antiseptic solution, also known as a hand disinfectant, hand antiseptic, hand rub. It is a liquid or gel containing alcohol use as an alternative to soap and water. It is used to clean the hands and kill infection-causing microorganisms. The main difference between washing hands with soap and hand sanitizer is soap work to remove all types of germs from hands, while sanitizer acts as killing germs present on the skin. It is an alcohol-based hand sanitizer work to reduce the number of germs but it is less effective in removing harmful chemicals, such as pesticides and heavy metals like lead. The report " Global Hand Sanitizers Market by Type (Gel, Foam, and Spray), By Application (Restaurant, Hospital, School, Household, and Office Building,), and By Region (North America, Europe, Asia Pacific, Latin Am
Read more

Sternal Closure Systems Market is estimated to be US$ 3.79 Billion by 2020 with a CAGR of 5.6% during the forecast period 2030

Image
  Sternal Closure Systems   Market  accounted for US$ 2.3 million in 2020 and is estimated to be US$ 3.79 billion by 2030 and is anticipated to register a CAGR of 5.6%.        The Sternal Closure Systems are used in bilateral thoracosternotomy, median sternotomy and hemisternotomy. Median sternotomy has become popular in early 1960s and remains gold standard approach in cardiac procedures. Sternal Closure Systems are used in stabilization and fixation of fractures at anterior part of chest wall. Change in lifestyle, lack of exercise and unhealthy diet has become common cause of cardiovascular diseases. Newly developed technology in medical field in metropolitan cities has given rise to heart surgeries which has boosts the Sternal Closure Systems Market. As cardiac surgeries had become routine surgery, it is determined that annually around one million heart surgeries are performed worldwide. Rate of coronary heart diseases are high in United States of America. According to data publishe
Read more